In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Fentanyl Citrate Injection is indicated for:
Fentanyl Citrate Injection should be administered only by persons specifically...
Fentanyl Citrate Injection is contraindicated in patients with:
Fentanyl Citrate Injection contains fentanyl, a Schedule CII controlled substance. As an opioid, Fentanyl...
The following serious adverse reactions are described, or described in greater detail, in other sections:
Table 2 includes clinically significant drug interactions with Fentanyl Citrate Injection.
Prolonged use of opioid...
Fentanyl Citrate Injection contains fentanyl, a Schedule II controlled substance.
Acute overdose with Fentanyl Citrate Injection can be manifested by respiratory depression,...
Fentanyl Citrate Injection is an opioid agonist. Fentanyl Citrate Injection, is a sterile, nonpyrogenic solution of fentanyl citrate in water for injection, available as 50 mcg (0.05 mg) per mL which is...
Fentanyl is an opioid agonist whose principal actions of therapeutic value are analgesic and sedation.
Fentanyl Citrate Injection, USP equivalent to 50 mcg (0.05 mg) fentanyl per mL, is supplied in single-dose glass containers as follows:
Inform patients that opioids could cause a rare but potentially life-threatening...
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 8AM-9PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.